References
- Youngren-Ortiz SR, Gandhi NS, Espaa-Serrano L, et al. Aerosol delivery of siRNA to the lungs. Part 2: nanocarrier-based delivery systems[J]. Kona Powder Sci Technol Japan. 2017;34(34):44.
- Liu C, Cheng F, Yang X. Fabrication of a soybean Bowman-Birk Inhibitor (BBI) nanodelivery carrier to improve bioavailability of curcumin[J]. J Agric Food Chemistry. 2017;65(11):2426–2434.
- Chakraborty A, Dhar. P. A review on potential of proteins as an excipient for developing a nano-carrier delivery system.[J]. Crit Rev Ther Drug Carrier Syst. 2017;34(5):453.
- Sree K, V Ruchi, PK Girish, K Lalit. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomedicine. 2017;12:15–28.
- Yu D, Wang X, Jiang R. Progress in antitumor nano-drug carrier[J]. Tumor. 2018;38(6):603–609.
- Baruah RR, Kalita MC, Devi D. Novel non-mulberry silk fibroin nanoparticles with enhanced activity as potential candidate in nanocarrier mediated delivery system[J]. RSC Adv. 2020;10(15):9070–9078.
- Su C, Y Liu, R Li, W Wu, J Gu. Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems. Adv Drug Deliv Rev. 2019;143:97–114.
- Patil JS, Naik JB. Carrier based oral nano drug delivery framework: a review[J]. Curr Nanomater. 2018;3(2):75–85.
- Marziyeh, Fathi, Parham, Sahandi, Zangabad, Jaleh, Barar, Ayuob, Aghanejad, Hamid. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib. Int J Biol Macromol Struct Funct Interact. 2018;106:266–276.
- Behzad M, Maysam P, Ebrahim GZ. An improved method for magnetic nanocarrier drug delivery across the cell membrane[J]. Sensors. 2018;18(2):381.
- Yangyang, Liu, Yancai, Wang, Juan, Zhao. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. Int J Biol Macromol. 2018;124:667–680.
- Xie S, Wang X, Ren J, et al. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma[J]. Eur Arch Oto Rhino Laryngol. 2017;274(5):2071–2078.
- Rcsa B, CCLC D, WAB Na, XTFA B, SHHA B, ZAB Jie, LXHA B, XZZ E, ATXA B. TFIIB-related factor 2 regulates glucose-regulated protein 78 expression in acquired middle ear cholesteatoma. Biochem Biophys Res Commun. 2021;540:95–100.
- Nagel J, W?llner S, Schürmann M, et al. Stem cells in middle ear cholesteatoma contribute to its pathogenesis[J]. Sci Rep. 2018;8(1):6204.
- Yamamoto-Fukuda T, N Akiyama, M Takahashi,H Kojima. Keratinocyte Growth Factor (KGF) modulates epidermal progenitor cell kinetics through activation of p63 in middle ear cholesteatoma[J]. J Assoc Res Otolaryngology. 2018;19(3):223–241.
- Sharma SD, A Hall, AC Bartley, P Bassett, RK Lingam. Surgical mapping of middle ear cholesteatoma with fusion of computed tomography and diffusion-weighted magnetic resonance images: diagnostic performance and interobserver agreement. Int J Pediatr Otorhinolaryngol. 2019;129:109788.
- Jeong H, DH Lee, JE Shin, CH Kim. Positional nystagmus in middle ear cholesteatoma with labyrinthine fistula. Med Hypotheses. 2020;144:110223.
- Karamert R, Fakih, Cihat, Eravc, Süleyman, Cebeci, Mehmet, Düzlü, Mehmet. Canal wall down versus canal wall up surgeries in the treatment of middle ear cholesteatoma[J]. Turk J Med Sci. 2019;49(5):1426–1432.
- Xie S, Wei L, Ren J. Reply to the Letter to the Editor regarding “Etiopathogenesis of bone resorption in acquired middle ear cholesteatoma”[J]. Archiv für Klinische und Experimentelle Ohren- Nasen- und Kehlkopfheilkunde. 2017;274(12):4253.
- Wang R, X Zheng, L Zhang, B Zhou, H Hu, Z Li, L Zhang, Y Lin, X Wang. Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade. Rep. 2017;7:41715.
- Long S, Hongfeng L, Biao Q, Wei Z, Jing J, Xujun L. MiRNA-10a-3p enhanced cell apoptosis by regulating pten/pi3k/akt signaling pathway in breast cancer[J]. Acta Med Mediterr. 2020;36(2):901–906.